Andrographis paniculata

'King of bitters' with limited, very-low-quality evidence for cough symptoms; NICE made no recommendation.

Evidence
Preliminary evidenceGRADE certainty: Very low
Typical dose
Standardised extract delivering 60–120 mg/day total andrographolides, typically divided three times daily for about 5 days from symptom onset
Time to effect
Onset is not well established
Safety
Has documented cautions

Evidence ratings summarise published research on Andrographis paniculata in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Andrographis paniculata

Interactions

Taking any medication?

Check Andrographis paniculata against it.

Why

Andrographis paniculata is a bitter herb widely used in Indian, Chinese, and Scandinavian phytotherapy. NICE guideline NG120 found it reduced cough frequency and severity compared with placebo, but rated the evidence very low quality, judged the clinical importance unclear, noted no safety data and made no recommendation for or against its use.

How it works

Andrographolides modulate cytokine signalling (TNF-α, IL-6), inhibit NF-κB, and show direct antiviral activity against influenza A in vitro. Mucosal immune effects are documented in animal models.

Expected onset · Onset is not well established

How to take

Dosage

Standardised extract delivering 60–120 mg/day total andrographolides, typically divided three times daily for about 5 days from symptom onset.

Timing

Three times daily with food, started at symptom onset

On the label

Look for extracts standardised to total andrographolides content (typically 4–6% in dried herb, 10%+ in concentrated extracts).

Studied in

Adults with cough from a cold or upper respiratory tract infection, looking for a botanical alternative to symptomatic OTCs.

Safety

Common GI side effects (loss of appetite, nausea, diarrhoea). Bitter taste can worsen reflux. Possible additive effects with antihypertensives and anticoagulants. Avoid in pregnancy (animal studies show reproductive toxicity). Allergic reactions, including anaphylaxis, are rare but reported. Limit use to acute episodes (1–2 weeks) rather than chronic use.
Loading interactions…

Evidence

At a glance

NICE guideline NG120 (2019) reviewed Andrographis paniculata for cough and colds and found it reduced cough frequency and severity compared with placebo, but rated the evidence very low quality. The committee considered the clinical importance unclear, noted that no safety data were available, and made no recommendation for or against its use.

GRADE certainty: Very low — reported by NICE NG120

Questions people ask

Does Andrographis paniculata work?

NICE guideline NG120 (2019) reviewed Andrographis paniculata for cough and colds and found it reduced cough frequency and severity compared with placebo, but rated the evidence very low quality. The committee considered the clinical importance unclear, noted that no safety data were available, and made no recommendation for or against its use. Certainty of the evidence: Very low, reported by NICE NG120.

How is Andrographis paniculata taken?

Standardised extract delivering 60–120 mg/day total andrographolides, typically divided three times daily for about 5 days from symptom onset. Timing: Three times daily with food, started at symptom onset. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Common GI side effects (loss of appetite, nausea, diarrhoea). Bitter taste can worsen reflux. Possible additive effects with antihypertensives and anticoagulants. Avoid in pregnancy (animal studies show reproductive toxicity). Allergic reactions, including anaphylaxis, are rare but reported. Limit use to acute episodes (1–2 weeks) rather than chronic use. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: NICE guideline (2019): Cough (acute): antimicrobial prescribing, NG120.

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.